CD Skripsi
Efek Nano-Kurkumin Terhadap Gambaran Histopatologi Ketebalan Miometrium Pada Hewan Model Adenomiosis
Adenomyosis, characterized by the invasion of endometrial tissue into the myometrium resulting in myometrial hypertrophy, is a gynecological disorder that requires new therapeutic approaches. This study aimed to evaluate the therapeutic potential of Nano-Curcumin, a high-bioavailability formulation possessing potent anti-inflammatory properties, against adenomyosis parameters in a rat model. The method used was an in vivo experimental design where adenomyosis model rats were divided into a negative control group and nano-curcumin therapy groups at doses of 50 mg/kgBW and 100 mg/kgBW. The therapy was administered orally, followed by the measurement of final body weight (BW), uterine weight, and histopathological analysis of myometrial thickness. The results showed that the nano-curcumin therapy groups experienced an increase in body weight (indicating metabolic improvement) and a significant reduction in uterine weight, where the 100 mg/kgBW dose provided the most optimal effect in lesion reduction and inflammation suppression. Although the uterine weight-to-body weight ratio did not differ significantly between groups, nano-curcumin proved to have a positive influence on reducing myometrial thickness. It was concluded that Nano-Curcumin possesses effective therapeutic potential for managing adenomyosis, with the 100 mg/kgBW dose being the most effective in reducing uterine weight and improving the myometrial histopathological profile in the animal model.
Keywords: Adenomyosis, Antioxidant, Anti-inflammatory, Curcumin, Estrogen, Myometrium, Nanocurcumin, Oxidative stress, VEGF
Tidak tersedia versi lain